Diana Learoyd
Professor
Endocrinology
University of Sydney
Australia
Biography
Dr.DIANA LEAROYD is a Professor of Medicine, Northern Clinical School.
Research Interest
Endocrinology
Publications
-
Fraser, S., Go, C., Aniss, A., Sidhu, S., Delbridge, L., Learoyd, D., Clifton-Bligh, R., Tacon, L., Tsang, V., Robinson, B., Gill, A., Sywak, M. (2016). BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. World Journal of Surgery, 40(7), 1618-1624.
-
Nixon, I., Wang, L., Migliacci, J., Eskander, A., Campbell, M., Aniss, A., Morris, L., Vaisman, F., Corbo, R., Momesso, D., Learoyd, D., Sywak, M., et al (2016). An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid, 26(3), 373-380.
-
Reagh, J., Bullock, M., Andrici, J., Turchini, J., Sioson, L., Clarkson, A., Watson, N., Sheen, A., Lim, G., Delbridge, L., Sidhu, S., Sywak, M., Learoyd, D., Robinson, B., Clifton-Bligh, R., Gill, A., et al (2017). NRASQ61R mutation-specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2. American Journal of Surgical Pathology, 41(1), 75-81.
